The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Transiderm-Nitro 15milligrams/24 hours Transdermal Patch



Sandoz Pharmaceuticals d.d.PA23311/005/003

Main Information

Trade NameTransiderm-Nitro 15milligrams/24 hours Transdermal Patch
Active SubstancesGlyceryl trinitrate
Dosage FormTransdermal patch
Licence HolderSandoz Pharmaceuticals d.d.
Licence NumberPA23311/005/003

Group Information

ATC CodeC01DA Organic nitrates
C01DA02 glyceryl trinitrate

Status

License statusAuthorised
Licence Issued11/01/1995
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back